A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B

Table 2 Adverse events documented during treatment

Adverse events	Group A	Group B	Group C
Patients (n)	21	21	19
Headache	7	6	7
Upper respiratory tract infection	3	3	4
Nasopharyngitis	4	3	4
Cough	2	2	1
Pyrexia	3	3	4
Upper abdominal pain	2	2	1
Fatigue	5	6	5
Diarrhea	7	6	6
Death	0	0	0
ALT > 2 × baseline > and 10 × ULN	4	1	2

ALT: alanine aminotransferase; ULN: upper limit of normal.